Results 121 to 130 of about 69,642 (298)

Yellow Fever Vaccination [PDF]

American Journal of Public Health and the Nations Health, 1956
K. C. SMITHBURN, C. DURIEUX, R. KOERBER, H. A. PENNA, G. W. A. DICK, G. COURTOIS, C. DESOUZA MANSO, G. STUART, P. H. BONNEL   +8 more
openaire   +4 more sources

Old vaccines, new usages, surprisingly effective in solving the century-old problem -Inactivated African Swine Fever Virus vaccine induces safe and efficient immune protection through mucosal immunity [PDF]

arXiv
Background: African swine fever is among the most devastating viral diseases of pigs. Despite nearly a century of research, there is still no safe and effective vaccine available. The current situation is that either vaccines are safe but not effective, or they are effective but not safe.Findings: The ASF vaccine prepared using the inactivation method ...
arxiv  

Peptides Corresponding to the Receptor‐Binding Domain (RBD) of Several SARS‐CoV‐2 Variants Of Concern Prevent Recognition of the Human ACE2 Receptor and Consecutive Cell Infections

ChemMedChem, Volume 20, Issue 7, April 1, 2025.
Despite the end of the COVID‐19 pandemic, SARS‐CoV‐2 will remain a constant factor in our lives. For this reason, the development of new preventive therapeutics is necessary. Here, the first steps were taken by testing peptides for their inhibitory activity on the binding between the human ACE‐2 receptor and the RBD of the virus.
Mandy Schwarze, Alexandra Brakel, Ralf Hoffmann, Andor Krizsan   +3 more
wiley   +1 more source

Effect of Land‐Use on Hantavirus Infection Among Introduced and Endemic Small Mammals of Madagascar

Ecology and Evolution, Volume 15, Issue 4, April 2025.
Addressing the risk of Hantavirus spillover from animal reservoirs to humans requires identifying the local reservoirs and the predictors of infection. We screened a collection of 1880 small mammals for Hantavirus RNA from northeastern Madagascar, and specifically investigated the influence of diverse natural or anthropized habitats as well as animal ...
Jérémy Dubrulle, Kayla Kauffman, Voahangy Soarimalala, Toky Randriamoria, Steven M. Goodman, James Herrera, Charles Nunn, Pablo Tortosa   +7 more
wiley   +1 more source

Narcolepsy following yellow fever vaccination: A case report

Frontiers in Neurology, 2016
Narcolepsy with cataplexy is a rare, but important differential diagnosis for daytime sleepiness and atonic paroxysms in an adolescent. A recent increase in incidence in the paediatric age-group probably linked to the use of the Pandremix influenza ...
Richard Ewald Rosch, Richard Ewald Rosch, Michael Farquhar, Paul Gringras, Deb K Pal, Deb K Pal   +5 more
doaj   +1 more source

Interaction of Yellow Fever Virus French Neurotropic Vaccine Strain with Monkey Brain: Characterization of Monkey Brain Membrane Receptor Escape Variants [PDF]

, 2000
Haolin Ni, Kate D. Ryman, Heiman Wang, Mohammad Saeed, Robin Hull, David Wood, Philip D. Minor, Stanley J. Watowich, Alan D.T. Barrett   +8 more
openalex   +1 more source

Recombinant Yellow Fever Viruses Are Effective Therapeutic Vaccines for Treatment of Murine Experimental Solid Tumors and Pulmonary Metastases [PDF]

, 2000
Andrés McAllister, Alejandra E. Arbetman, Stefanie Mandl, Claudia Peña-Rossi, Raul Andino   +4 more
openalex   +1 more source

Altered Circulating Cytokine Profile Among mRNA‐Vaccinated Young Adults: A Year‐Long Follow‐Up Study

Immunity, Inflammation and Disease, Volume 13, Issue 4, April 2025.
ABSTRACT Objectives This longitudinal study aimed to assess the impact of COVID‐19 vaccination on cytokine profile. Methods A total of 84 Saudi subjects (57.1% females) with mean age of 27.2 ± 12.3 participated in this longitudinal study. Anthropometric data and fasting blood samples were obtained at baseline and after final vaccination, with an ...
Amani Alghamdi, Syed Danish Hussain, Kaiser Wani, Shaun Sabico, Abdullah M. Alnaami, Osama Emam Amer, Nasser M. Al‐Daghri   +6 more
wiley   +1 more source

[The immune state against yellow fever vaccinal virus (17D) in 2 populations of Bahia State, Brazil] [PDF]

, 2000
Sandro Santos-Torres, Andréa Straatmann, Kátia Nunes Silva Mota, Vasconcelos Pf, da Rosa Ap, José Tavares‐Neto   +5 more
  +3 more sources

Risk of Serious Infections in Patients Treated With Biologic or Targeted‐synthetic Disease Modifying Antirheumatic Drugs in Qatar

Immunity, Inflammation and Disease, Volume 13, Issue 4, April 2025.
This study investigates the risk of serious infections (SIs) in patients treated with biologic or targeted‐synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) in Qatar. Out of 1092 patients, 86 (7.9%) experienced SIs, with adalimumab and infliximab associated with higher SI rates.
Sreethish Sasi, Hamad Abdel Hadi, Masautso Chaponda, Reem El Ajez, Mohamed Ataelmanan, Sief Khasawneh, Hind Saqallah, Maisa Ali, Nabeel Abdulla, Javed Iqbal, Ali S. Omrani, Muna Al Maslamani, Abdullatif Al‐Khal   +12 more
wiley   +1 more source